Last10K.com

Affimed N.V. (AFMD) SEC Filing 6-K Foreign Issuer Report for the period ending Tuesday, November 15, 2022

Affimed N.V.

HISTORY TOOLS
CIK: 1608390 Ticker: AFMD

View differences made from one to another to evaluate Affimed N.V.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Affimed N.V..

Continue

Assess how Affimed N.V.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Affimed N.V.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Affimed N.V. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Exhibit 99.3: Additional Exhibits
Ticker: AFMD
CIK: 1608390
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001193125-22-285223
Submitted to the SEC: Tue Nov 15 2022 6:42:30 AM EST
Accepted by the SEC: Tue Nov 15 2022
Period: Tuesday, November 15, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/afmd/0001193125-22-285223.htm